Table 3 Correlation between clinical characteristics and PIK3CA mutations
Characteristics | n = 95 | PIK3CA mutant-type | PIK3CA wild-type | P value* |
|---|---|---|---|---|
No. of patient (n = 19) | No. of patient (n = 76) | |||
Mean age (SD) | 49.7 (13.2) | 56.6 (10.7) | 48.2 (13.7) | 0.007 |
FIGO stage | ||||
 Stage I | 84 (88.4%) | 16 (16.8%) | 68 (71.6%) | 0.688 |
 Stage II–III | 11 (11.6%) | 3 (3.2%) | 8 (8.4%) | |
Tumor size | ||||
 ≤2 cm | 11 | 1 | 10 | 0.433 |
 >2–5 cm | 69 | 16 | 53 | |
 >5 cm | 15 | 2 | 13 | |
Lymphnode | ||||
 Positive | 17 | 5 | 12 | 0.337 |
 Negative | 61 | 11 | 50 | |
 No data | 17 |  |  | |
Histology | ||||
 Well | 16 (16.8%) | 2 (2.1%) | 14 (14.7%) | 0.547 |
 Moderately | 65 (68.4%) | 13 (13.7%) | 52 (54.7%) | |
 Poorly | 14 (14.7%) | 4 (4.2%) | 10 (10.5%) | |